supp.fit

Caprylic Acid: study protocols

7 study groups say how much Caprylic Acid participants took a day. These are the doses the studies gave. They are not a recommendation.

Caprylic Acid: what the research found →

Dose per serving from products

321 products in our catalogue print how much Caprylic Acid a serving holds.

Most common: 250 mg to 500 mg, 45% of 321 products.

Dose per servingProducts
50 mg or less
5
50 mg to 100 mg
18
100 mg to 250 mg
31
250 mg to 500 mg
144
500 mg to 1 g
31
1 g to 2.5 g
30
2.5 g to 5 g
19
5 g to 10 g
38
over 10 g
5

Dose per serving from research

7 study groups in 2 studies say how much Caprylic Acid participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 100 mg to 250 mg, 57% of 7 study groups.

Daily doseStudy groups
100 mg or less
1
100 mg to 250 mg
4
250 mg to 500 mg
0
500 mg to 1 g
0
1 g to 2.5 g
0
2.5 g to 5 g
0
5 g to 10 g
0
10 g to 25 g
2

Commonly used together

7 of 7 study groups took Caprylic Acid with something else, but nothing that 3 or more different studies gave.

7 study groups

Study
Supplementation of medium-chain triglycerides combined with docosahexaenoic acid improves cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial
2025 · MCT group · Chinese older adults with mild cognitive impairment
14 g1 year70
Supplementation of medium-chain triglycerides combined with docosahexaenoic acid improves cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial
2025 · MCT + DHA group · Chinese older adults with mild cognitive impairment
14 g1 year70
Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover
2004 · 0.15 mg daily sCT · Healthy postmenopausal women aged 55–85 years
200 mg90 days—
Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover
2004 · 0.4 mg daily sCT · Healthy postmenopausal women aged 55–85 years
200 mg90 days—
Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover
2004 · 1.0 mg daily sCT · Healthy postmenopausal women aged 55–85 years
200 mg90 days—
Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover
2004 · 2.5 mg daily sCT · Healthy postmenopausal women aged 55–85 years
200 mg90 days—
Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover
2004 · 1.0 mg intermittent sCT (every other day) · Healthy postmenopausal women aged 55–85 years
100 mg90 days—